Chinese Congress Passes New Law Covering Product Liability For Drugs And Devices, Along With Medical Malpractice
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Chinese President Hu Jintao has signed an extensive new "Tort Law of the People's Republic of China" covering medical malpractice, product liability and related provisions that could affect companies across the life sciences with operations in China